Fetal androgen exposure plays a pivotal role in Polycystic ovary syndrome (PCOS) development and may result in elevated Anogenital distance (AGD). This meta-analysis aimed to investigate the clinical link between PCOS and AGD.
Methods
A literature search was performed across various databases to identify studies evaluating AGD in adults with PCOS and without, regardless of language, up to December 2024. The quality of the studies was evaluated using the Newcastle-Ottawa Scale (NOS) scoring system. Random-effects models were utilized to determine mean differences (MDs) and 95% confidence intervals (CIs) in cases of high heterogeneity. This meta-analysis encompassed 4 studies involving a total of 837 participants.
Results
The pooled analysis found a noteworthy increase of the AGD-ac and AGD-af in PCOS patient compared with the control groups, with an overall MD of AGD-ac = 5.23, 95% CI (2.60, 7.85), P-value < 0.0001, I2 = 57%, and with an overall MD of AGD-af = 2.19, 95% CI (0.04, 4.35), P-value = 0.05, I2= 89%.
Conclusion
The meta-analysis results indicated that women diagnosed with PCOS exhibit elongated AGD. This potential association between AGD and PCOS could serve as a novel clinical marker for the diagnosis of PCOS. Fetal androgen exposure may play a role in the pathogenesis of PCOS.
Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod2004; 19: 41–47.
2.
Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril2004; 81: 19–25.
3.
LiznevaDKirubakaranRMykhalchenkoK, et al.Phenotypes and body mass in women with polycystic ovary syndrome identified in referral versus unselected populations: systematic review and meta-analysis. Fertil Steril2016; 106: 1510–1520.e2.
4.
AzzizR. PCOS: a diagnostic challenge. Reprod Biomed Online2004; 8: 644–648.
5.
AzzizRCarminaEDewaillyD, et al.Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an androgen excess society guideline. J Clin Endocrinol Metab2006; 91: 4237–4245.
6.
RosnerWAuchusRJAzzizR, et al.Position statement: utility, limitations, and pitfalls in measuring testosterone: an endocrine society position statement. J Clin Endocrinol Metab2007; 92: 405–413.
7.
CattrallFRVollenhovenBJWestonGC. Anatomical evidence for in utero androgen exposure in women with polycystic ovary syndrome. Fertil Steril2005; 84: 1689–1692.
8.
AbbottDHBarnettDKBrunsCM,et al.Androgen excess fetal programming of female reproduction: a developmental aetiology for polycystic ovary syndrome?Hum Reprod Update. 2005; 11: 357–374.
9.
RisalSPeiYLuH, et al.Prenatal androgen exposure and transgenerational susceptibility to polycystic ovary syndrome. Nat Med2019; 25: 1894–1904.
WuXYLiZLWuCY, et al.Endocrine traits of polycystic ovary syndrome in prenatally androgenized female sprague-dawley rats. Endocr J2010; 57: 201–209.
12.
ThankamonyAPasterskiVOngKK, et al.Anogenital distance as a marker of androgen exposure in humans. Andrology2016; 4: 616–625.
13.
PeretzJVroomanLRickeWA, et al.Bisphenol A and reproductive health: update of experimental and human evidence, 2007–2013. Environ Health Perspect2014; 122: 775–786.
14.
SwanSHSathyanarayanaSBarrettES, et al.First trimester phthalate exposure and anogenital distance in newborns. Hum Reprod2015; 30: 963–972.
15.
DuralOKurbanovaTYasaC, et al.Idiopathic primary ovarian insufficiency is associated with anogenital distance, a marker for prenatal environment. Eur J Obstet Gynecol Reprod Biol2021; 258: 304–308.
16.
Mira-EscolanoMPMendiolaJMínguez-AlarcónL, et al.Longer anogenital distance is associated with higher testosterone levels in women: a cross-sectional study. BJOG2014; 121: 1359–1364.
17.
WuYZhongGChenS, et al.Polycystic ovary syndrome is associated with anogenital distance, a marker of prenatal androgen exposure. Hum Reprod2017; 32: 937–943.
18.
SimsirCPekcanMKAksoyRT, et al.The ratio of anterior anogenital distance to posterior anogenital distance: a novel-biomarker for polycystic ovary syndrome. J Chin Med Assoc2019; 82: 782–786.
19.
Sanchez-FerrerMLMendiolaJHernandez-PenalverAI, et al.Presence of polycystic ovary syndrome is associated with longer anogenital distance in adult Mediterranean women. Hum Reprod2017; 32: 2315–2323.
20.
PetersHELaevenCHCTrimbosCJMA, et al.Anthropometric biomarkers for abnormal prenatal reproductive hormone exposure in women with Mayer-Rokitanksy-Ku Euro ster-Hauser syndrome, polycystic ovary syndrome, and endometriosis. Fertil Steril2020; 114: 1297–1305.
21.
HafizovićLČauševićADeumićA, et al.The use of artificial intelligence in diagnostic medical imaging: systematic literature review. 2021 IEEE 21st International Conference on Bioinformatics and Bioengineering (BIBE), Kragujevac, Serbia, 2021, pp. 1–6.
22.
HrvatFSpahićLPokvićLG,et al.Artificial neural networks for prediction of medical device performance based on conformity assessment data: infusion and perfusor pumps case study. 2020 9th Mediterranean Conference on Embedded Computing (MECO), Budva, Montenegro, 2020, pp. 1–4.
23.
BadnjevicACifrekMKorugaD. Classification of Chronic Obstructive Pulmonary Disease (COPD) using integrated software suite. In: Roa RomeroL (ed.) XIII Mediterranean conference on medical and biological engineering and computing 2013. IFMBE Proceedings, vol 41. Cham: Springer, 2014, pp.911–914.
24.
VeljovićEŠpirtović-HalilovićSMuratovićS, et al.artificial neural network and docking study in design and synthesis of xanthenes as antimicrobial agents. In: BadnjevicA (ed.) CMBEBIH 2017. IFMBE Proceedings, vol 62. Singapore: Springer, 2017, pp.617–626.
25.
StangA. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol2010; 25: 603–605.
26.
Hernandez-PenalverAISanchez-FerrerMLMendiolaJ, et al.Assessment of anogenital distance as a diagnostic tool in polycystic ovary syndrome. Reprod Biomed Online2018; 37: 741–749.
27.
EhrmannDA. Polycystic ovary syndrome. N Engl J Med2005; 352: 1223–1236.
FranksSMcCarthyMIHardyK. Development of polycystic ovary syndrome: involvement of genetic and environmental factors. Int J Androl2006; 29: 278–285.
30.
CrespiBJEvansSF. Prenatal origins of endometriosis pathology and pain: reviewing the evidence of a role for low testosterone. J Pain Res2023; 16: 307–316.
31.
CrespiB. Variation among human populations in endometriosis and PCOS A test of the inverse comorbidity model. Evol Med Public Health2021; 9: 295–310.
32.
BuggioLBarbaraGDridiD, et al.Anogenital distance and gynaecological diseases: a narrative review. Italian J Gynaecol Obst2020; 32: 200–207.
33.
JainVGGoyalVChowdharyV, et al.Anogenital distance is determined during early gestation in humans. Hum Reprod2018; 33: 1619–1627.
34.
BarrettESParlettLESwanSH. Stability of proposed biomarkers of prenatal androgen exposure over the menstrual cycle. J Dev Orig Health Dis2015; 6: 149–157.
35.
ThankamonyAOngKKDungerDB, et al.Anogenital distance from birth to 2 years: a population study. Environ Health Perspect2009; 117: 1786–1790.
36.
WainstockTShoham-VardiISheinerE,et al.Fertility and anogenital distance in women. Reprod Toxicol2017; 73: 345–349.
37.
VermaPMaanPGautamR,et al.Unveiling the role of Artificial Intelligence (AI) in Polycystic Ovary Syndrome (PCOS) diagnosis: a comprehensive review. Reprod Sci2024; 31(10): 2901–2915.
